Carboplatin Injection 10 mg/mL sterile solution is available in the following presentations:
| Unit of Sale | Concentration |
|---|---|
NDC 61703-339-18 | 50 mg/5 mL |
NDC 61703-339-22 | 150 mg/15 mL |
NDC 61703-339-50 | 450 mg/45 mL |
NDC 61703-339-56 | 600 mg/60 mL |
Unopened vials of Carboplatin Injection are stable to the date indicated on the package when stored at 25°C (77°F); excursions permitted from 15°–30°C (59°–86°F) [see USP Controlled Room Temperature]. Protect from light.
Carboplatin Injection multiple-dose vials maintain microbial, chemical, and physical stability for up to 14 days at 25°C following multiple needle entries.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Solutions for infusion should be discarded 8 hours after preparation.
Carboplatin Injection 10 mg/mL sterile solution is available in the following presentations:
| Unit of Sale | Concentration |
|---|---|
NDC 61703-339-18 | 50 mg/5 mL |
NDC 61703-339-22 | 150 mg/15 mL |
NDC 61703-339-50 | 450 mg/45 mL |
NDC 61703-339-56 | 600 mg/60 mL |
Unopened vials of Carboplatin Injection are stable to the date indicated on the package when stored at 25°C (77°F); excursions permitted from 15°–30°C (59°–86°F) [see USP Controlled Room Temperature]. Protect from light.
Carboplatin Injection multiple-dose vials maintain microbial, chemical, and physical stability for up to 14 days at 25°C following multiple needle entries.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Solutions for infusion should be discarded 8 hours after preparation.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.